EquityZen Growth Technology Fund LLC - Series 1812
Raised
$475K
Investors
27
Min Invest
$10,005
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1812 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett. The entity raised $475K from 27 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This is part of the EquityZen platform, which has 150 related EDGAR entities focused on private equity investments.
This filing represents a typical small-scale private equity SPV within the EquityZen platform ecosystem, using the standard 506(b)/3(c)(1) exemption structure. The $10K minimum investment and sub-$500K raise size are consistent with single-company investment vehicles targeting accredited investors, placing it in the lower-mid tier of accessibility for private equity exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
